Iradimed (IRMD) FCF Margin (2013 - 2026)

Iradimed (IRMD) has reported FCF Margin for 14 consecutive years, with 28.12% the latest figure, recorded in Q2 2026.

• On a quarterly basis, FCF Margin rose 308.0% year-over-year to 28.12% in Q2 2026; TTM through Jun 2026 was 29.09%, a 1079.0% increase from a year earlier, with the FY2025 full-year figure at 20.5%, down 356.0% from the prior year.
• FCF Margin was 28.12% for Q2 2026 at Iradimed, down from 35.88% in the prior quarter.
• Over five years, FCF Margin peaked at 35.88% in Q1 2026 and troughed at 11.31% in Q1 2023.
• A 5-year average of 19.04% and a median of 20.52% in 2023 frame the typical range for FCF Margin.
• Across the five-year window, FCF Margin sank 2425 bps in 2022 and surged 3283 bps in 2026, its largest moves.
• Over 5 years, FCF Margin stood at 19.01% in 2022, then rose by 2 bps to 19.37% in 2023, then retreated by 15 bps to 16.49% in 2024, then jumped by 50 bps to 24.8% in 2025, then rose by 13 bps to 28.12% in 2026.
• The last three FCF Margin figures came in at 28.12% (Q2 2026), 35.88% (Q1 2026), and 24.8% (Q4 2025), per Business Quant data.